How Pharmacogenomics Can Benefit Your Clinical Trial
Conversations in Drug Development Trends
MARCH 20, 2024
As the study of how an individual’s genes affect their response to drugs, pharmacogenomics is a critical factor in developing effective and safe drugs and dosages in clinical trials. However, certain variants may not metabolize this blood thinner as efficiently, rendering the treatment less effective in those participants.
Let's personalize your content